News
UK primary care group adopts digital heart failure pathway
A digital approach to the care of patients with heart failure, …
19773 items found
News
Pfizer drops twice-daily obesity therapy due to side effects
Pfizer has decided to discontinue the development of another of its …
News
Undiagnosed dementia in UK needs drastic action, says review
A just-published report has found that more than a third (36%) of …
Sales & Marketing
Building vs buying: How to best implement data analysis systems in pharma sales
That data analytics can help pharmaceutical firms advance their …
News
Roche makes obesity play with $2.7bn deal to buy Carmot
Roche has agreed a deal to acquire US biotech Carmot Therapeutics …
News
AstraZeneca links with Absci on AI for biologics discovery
AstraZeneca has agreed a deal worth up to $247 million with US …
News
MSD, Amgen back patient data specialist Culmination Bio
The venture capital arms of MSD and Amgen have provided $10 million …
News
FDA starts review of Padcev/Keytruda for bladder cancer
The FDA has kicked off a priority review of a new combination regimen …
News
AZ drops two trials aimed at expanding Lokelma’s label
AstraZeneca has decided to abandon two phase 3 trials of its drug to …
News
Cybin preps for ph3 as psychedelic clears depression trial
Cybin has unveiled phase 2 results with its psychedelic medicine for …
R&D
How to advance more late-stage neuroscience drugs to regulatory approval
As a practicing neuropsychiatrist for more than a decade, I witnessed …
News
AbbVie agrees $10.1bn deal to buy ImmunoGen
AbbVie has moved to shore up its pipeline following the loss of …
News
Lexicon's type 1 diabetes drug voted down by FDA adcomm
It has been five years since Lexicon Pharma's type 1 diabetes therapy Zynquista was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
